515 related articles for article (PubMed ID: 15921377)
1. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
2. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
3. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
LaTemple DC; Henion TR; Anaraki F; Galili U
Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
[TBL] [Abstract][Full Text] [Related]
5. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
6. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Galili U; Chen ZC; DeGeest K
Gynecol Oncol; 2003 Jul; 90(1):100-8. PubMed ID: 12821349
[TBL] [Abstract][Full Text] [Related]
8. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
10. Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes.
Galili U; Chen ZC; Manches O; Plumas J; Preisler H
J Hematother Stem Cell Res; 2001 Aug; 10(4):501-11. PubMed ID: 11522233
[TBL] [Abstract][Full Text] [Related]
11. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Abdel-Motal UM; Guay HM; Wigglesworth K; Welsh RM; Galili U
J Virol; 2007 Sep; 81(17):9131-41. PubMed ID: 17609270
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
14. Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Taniyama K; Kamiike W; Mori M; Doki Y
Cancer Sci; 2013 Mar; 104(3):282-90. PubMed ID: 23240661
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
17. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
Ogawa H; Yin DP; Galili U
Gene Ther; 2004 Feb; 11(3):292-301. PubMed ID: 14737089
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
[TBL] [Abstract][Full Text] [Related]
20. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
